The protective effect of IGF-2 appeared independent of the cause of degeneration, which is promising for future therapeutic purposes, as the pathways of motor neuron degeneration in ALS could vary from case to case. The gene discussed is IGF2; the disease is amyotrophic lateral sclerosis.